70.44
price up icon4.57%   3.09
after-market アフターアワーズ: 70.44
loading
前日終値:
$67.35
開ける:
$70.81
24時間の取引高:
8.89M
Relative Volume:
0.93
時価総額:
$238.77B
収益:
$43.59B
当期純損益:
$15.04B
株価収益率:
20.86
EPS:
3.3766
ネットキャッシュフロー:
$10.74B
1週間 パフォーマンス:
+3.26%
1か月 パフォーマンス:
+13.44%
6か月 パフォーマンス:
-33.64%
1年 パフォーマンス:
-48.23%
1日の値動き範囲:
Value
$69.87
$71.30
1週間の範囲:
Value
$66.36
$71.30
52週間の値動き範囲:
Value
$57.00
$148.15

Novo Nordisk Adr Stock (NVO) Company Profile

Name
名前
Novo Nordisk Adr
Name
セクター
Healthcare (1173)
Name
電話
-
Name
住所
-
Name
職員
77,406
Name
Twitter
@novonordisk
Name
次回の収益日
2024-12-06
Name
最新のSEC提出書
Name
NVO's Discussions on Twitter

NVO を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Drug Manufacturers - General icon
NVO
Novo Nordisk Adr
70.43 297.80B 43.59B 15.04B 10.74B 3.3766
Drug Manufacturers - General icon
LLY
Lilly Eli Co
724.13 677.89B 49.00B 11.11B -1.27B 12.29
Drug Manufacturers - General icon
JNJ
Johnson Johnson
153.24 366.90B 89.33B 21.81B 18.57B 8.99
Drug Manufacturers - General icon
ABBV
Abbvie Inc
185.47 328.04B 57.37B 4.20B 15.39B 2.35
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
113.17 218.66B 53.22B 12.86B 14.85B 6.39

Novo Nordisk Adr Stock (NVO) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-04-17 ダウングレード BMO Capital Markets Outperform → Market Perform
2025-03-13 アップグレード Kepler Hold → Buy
2025-03-03 ダウングレード Stifel Buy → Hold
2025-02-12 開始されました Morgan Stanley Equal-Weight
2025-01-06 アップグレード Bernstein Underperform → Mkt Perform
2024-05-30 開始されました Goldman Buy
2024-04-12 開始されました BMO Capital Markets Outperform
2024-01-23 開始されました Morgan Stanley Overweight
2024-01-16 再開されました UBS Neutral
2023-12-01 開始されました Cantor Fitzgerald Overweight
2023-10-02 開始されました Argus Buy
2023-07-14 開始されました HSBC Securities Buy
2022-07-15 アップグレード Morgan Stanley Equal-Weight → Overweight
2022-06-28 ダウングレード UBS Neutral → Sell
2022-06-27 アップグレード Exane BNP Paribas Underperform → Neutral
2022-06-07 アップグレード JP Morgan Neutral → Overweight
2022-05-31 アップグレード Guggenheim Neutral → Buy
2022-04-25 アップグレード Cowen Market Perform → Outperform
2022-04-12 アップグレード Morgan Stanley Underweight → Equal-Weight
2022-03-16 アップグレード Deutsche Bank Hold → Buy
2022-01-25 ダウングレード Liberum Hold → Sell
2021-12-20 ダウングレード JP Morgan Overweight → Neutral
2021-12-17 ダウングレード Deutsche Bank Buy → Hold
2021-01-20 ダウングレード Credit Suisse Outperform → Neutral
2021-01-15 開始されました Deutsche Bank Buy
2020-09-29 開始されました Berenberg Hold
2020-07-06 ダウングレード BofA Securities Buy → Neutral
2020-05-11 ダウングレード UBS Buy → Neutral
2020-05-04 開始されました Cowen Market Perform
2020-03-16 アップグレード BofA/Merrill Neutral → Buy
2020-01-03 ダウングレード Guggenheim Buy → Neutral
2019-11-18 アップグレード Barclays Equal Weight → Overweight
2019-09-17 アップグレード Citigroup Neutral → Buy
2019-08-30 ダウングレード Jefferies Hold → Underperform
2019-06-20 ダウングレード Deutsche Bank Buy → Hold
2019-06-11 アップグレード Barclays Underweight → Equal Weight
2019-04-29 アップグレード Credit Suisse Neutral → Outperform
2019-01-29 開始されました Exane BNP Paribas Outperform
2018-12-11 再開されました Jefferies Hold
2018-10-09 開始されました Guggenheim Buy
2017-12-29 アップグレード JP Morgan Underweight → Neutral
2017-12-06 アップグレード BofA/Merrill Neutral → Buy
2017-12-01 アップグレード Morgan Stanley Equal-Weight → Overweight
2017-09-25 ダウングレード Exane BNP Paribas Outperform → Neutral
2017-09-06 アップグレード BofA/Merrill Underperform → Neutral
すべてを表示

Novo Nordisk Adr (NVO) 最新ニュース

pulisher
May 21, 2025

GLP-1R Agonists Label Extensions/Drug Repurposing Market Overview 2025 | Novo Nordisk and Eli Lilly Lead, but New Entrants Eye GLP-1RA Market Opportunities - GlobeNewswire Inc.

May 21, 2025
pulisher
May 19, 2025

Novo Nordisk Faces Obesity Competition, but Innovation Still Warrants a Wide Moat - Morningstar

May 19, 2025
pulisher
May 19, 2025

Bio/Pharmaceutical Outsourcing Report, March 2025 Edition - GlobeNewswire Inc.

May 19, 2025
pulisher
May 16, 2025

European ADRs Dip As Pharma And Tech Stocks See Mixed Results - Finimize

May 16, 2025
pulisher
May 13, 2025

What Did We Find About Insider Trading At Novo Nordisk ADR (NYSE: NVO)? - Stocksregister

May 13, 2025
pulisher
May 09, 2025

Novo Nordisk Q1 Earnings Match Estimates, Revenues Rise Y/Y, Stock Up - MSN

May 09, 2025
pulisher
May 08, 2025

Novo Nordisk ADR earnings beat by $5.64, revenue topped estimates - Investing.com Nigeria

May 08, 2025
pulisher
May 07, 2025

Novo Nordisk Earnings: Compounders Pressured Q1 Wegovy Sales - Morningstar

May 07, 2025
pulisher
May 07, 2025

Novo Nordisk Earnings: Compounders Pressured Q1 Wegovy Sales, but Strategy Should Preserve Growth - Morningstar

May 07, 2025
pulisher
May 07, 2025

European ADRs See Mixed Results With Modest Gains - Finimize

May 07, 2025
pulisher
May 07, 2025

Novo Nordisk expects U.S. sales of Wegovy weight-loss drug to recover soon, CEO says - The Globe and Mail

May 07, 2025
pulisher
May 07, 2025

Market news - investments.halifax.co.uk

May 07, 2025
pulisher
May 07, 2025

Novo Nordisk cuts guidance but says generic competition will ease - Sharecast.com

May 07, 2025
pulisher
May 06, 2025

NOVO_B Stock Price and Chart — OMXCOP:NOVO_B - TradingView

May 06, 2025
pulisher
May 02, 2025

Novo Nordisk A/S Common Stock (NY: NVO - FinancialContent

May 02, 2025
pulisher
May 02, 2025

Novo Nordisk Stock Price Today | NYSE: NVO Live - Investing.com

May 02, 2025
pulisher
May 02, 2025

European Stocks Shine In US With ADR Gains - Finimize

May 02, 2025
pulisher
Apr 30, 2025

European ADRs Show Strength With Genfit And Novo Nordisk Leading Gains - Finimize

Apr 30, 2025
pulisher
Apr 29, 2025

Novo Nordisk ADR [NVO] Revenue clocked in at $42.09 billion, down -27.20% YTD: What’s Next? - dbtnews.com

Apr 29, 2025
pulisher
Apr 29, 2025

Novo Nordisk ADR (NVO) Stock: A Year of Market Fluctuations - investchronicle.com

Apr 29, 2025
pulisher
Apr 28, 2025

Novo Nordisk ADR [NVO] Investment Appeal on the Rise - knoxdaily.com

Apr 28, 2025
pulisher
Apr 26, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 26, 2025
pulisher
Apr 25, 2025

Novo Nordisk ADR (NYSE:NVO)’s 12-Month Price Target Currently Stands At 160 - Marketing Sentinel

Apr 25, 2025
pulisher
Apr 24, 2025

Stocks of Novo Nordisk ADR (NVO) are poised to climb above their peers - Sete News

Apr 24, 2025
pulisher
Apr 23, 2025

3 ‘buy the dip’ candidates with wide moats - Morningstar

Apr 23, 2025
pulisher
Apr 22, 2025

An Analysis of E-Home Household Service Holdings Ltd (EJH)’s Potential Price Growth - knoxdaily.com

Apr 22, 2025
pulisher
Apr 22, 2025

Taking a Closer Look At Novo Nordisk ADR (NVO) Following Its Recent Trade - knoxdaily.com

Apr 22, 2025
pulisher
Apr 22, 2025

Recent Insider Activity Could Benefit Vodafone Group plc ADR (VOD) - knoxdaily.com

Apr 22, 2025
pulisher
Apr 22, 2025

Balance Sheet Breakdown: Novo Nordisk ADR (NVO)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - DWinneX

Apr 22, 2025
pulisher
Apr 21, 2025

Novo Nordisk ADR (NVO) Stock: Uncovering a 52-Week Range and Trading Volume - investchronicle.com

Apr 21, 2025

Novo Nordisk Adr (NVO) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
drug_manufacturers_general NVS
$113.78
price up icon 0.76%
drug_manufacturers_general MRK
$77.70
price up icon 0.39%
drug_manufacturers_general GSK
$39.44
price up icon 1.37%
$184.69
price up icon 0.46%
$273.12
price up icon 0.65%
大文字化:     |  ボリューム (24 時間):